Observational case series on a group of patients with severe psoriasis who failed to respond to antitumour necrosis factor α biologics and switched to ustekinumab

被引：13
|
作者：
Downs, A. M. R. [1 ]
机构：
[1] Royal Devon & Exeter NHS Fdn Trust Hosp, Dept Dermatol, Exeter EX2 5DW, Devon, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2010年 / 163卷 / 02期
关键词：
psoriasis; ustekinumab; INTERLEUKIN-12/23; MONOCLONAL-ANTIBODY; BODY-MASS INDEX; DOUBLE-BLIND; TRIAL; EFFICACY; WEIGHT; SAFETY;
D O I：
10.1111/j.1365-2133.2010.09832.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：433 / 434
页数：2
相关论文
共 12 条
  • [1] Observational case series on a group of psoriasis patients who failed to respond to any TNF blockers
    Viguier, Manuelle
    Livideanu, Cristina
    Beylot-Barry, Marie
    Richard, Marie-Aleth
    Paul, Carle
    Bachelez, Herve
    Aubin, Francois
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2014, 25 (01) : 75 - 77
  • [2] Practical experience of ustekinumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to previous tumor necrosis factor blockers
    Wang, Tzu-Chang
    Chiu, Hsien-Yi
    Wang, Ting-Shun
    Tsai, Tsen-Fang
    DERMATOLOGICA SINICA, 2015, 33 (01) : 5 - 10
  • [3] Switching to adalimumab in patients with moderate to severe psoriasis who have failed on etanercept: a retrospective case cohort study
    Woolf, R. T.
    Smith, C. H.
    Robertson, K.
    Barker, J. N. W. N.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (04) : 889 - 892
  • [4] Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland
    Finckh, A.
    Tellenbach, C.
    Herzog, L.
    Scherer, A.
    Moeller, B.
    Ciurea, A.
    von Muehlenen, I
    Gabay, C.
    Kyburz, D.
    Brulhart, L.
    Mueller, R.
    Hasler, P.
    Zufferey, P.
    RMD OPEN, 2020, 6 (01):
  • [5] Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting
    Navarro, R.
    Vilarrasa, E.
    Herranz, P.
    Puig, L.
    Bordas, X.
    Carrascosa, J. M.
    Taberner, R.
    Ferran, M.
    Garcia-Bustinduy, M.
    Romero-Mate, A.
    Pedragosa, R.
    Garcia-Diez, A.
    Dauden, E.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (03) : 609 - 616
  • [6] Treatment efficacy and patient satisfaction of ustekinumab compared with tumor necrosis factor-alpha inhibitors in Chinese patients with moderate-to-severe psoriasis: a real-world study
    Guo, Bin
    Jin, Xiaobo
    Fan, Leiqiang
    Zhang, Yanfeng
    Xu, Bing
    Yang, Tao
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [7] Comparison of tuberculin skin test and interferon-γ assays in patients with moderate to severe psoriasis who are candidates for antitumour necrosis factor-α therapy
    Balato, N.
    Ayala, F.
    Gaudiello, F.
    Monfrecola, G.
    Cimmino, G.
    Ponticiello, A.
    Bocchino, M.
    Matarese, A.
    Sanduzzi, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 158 (04) : 847 - 849
  • [8] Combination of antitumour necrosis factor-α and anti-interleukin-12/23 antibodies in refractory psoriasis and psoriatic arthritis: a long-term case-series observational study
    Gniadecki, R.
    Bang, B.
    Sand, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 174 (05) : 1145 - 1146
  • [9] Cariprazine augmentation in patients with treatment resistant unipolar depression who failed to respond to previous atypical antipsychotic add-on. A case-series
    Pessina, Enrico
    Martini, Azzurra
    Raffone, Fabiola
    Martiadis, Vassilis
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [10] Rituximab or a Second Anti-Tumor Necrosis Factor Therapy for Rheumatoid Arthritis Patients Who Have Failed Their First Anti-Tumor Necrosis Factor Therapy? Comparative Analysis From the British Society for Rheumatology Biologics Register
    Soliman, Moetaza M.
    Hyrich, Kimme L.
    Lunt, Mark
    Watson, Kath D.
    Symmons, Deborah P. M.
    Ashcroft, Darren M.
    ARTHRITIS CARE & RESEARCH, 2012, 64 (08) : 1108 - 1115
12